Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BREO ELLIPTA vs BRIGATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BREO ELLIPTA vs BRIGATINIB: Safety Overview

Metric BREO ELLIPTA BRIGATINIB
Total FAERS Reports 218 3,286
Deaths Reported 1 729
Death Rate 0.5% 22.2%
Hospitalizations 20 912
Average Patient Age 70.0 yrs 61.2 yrs
% Female Patients N/A 57.3%
FDA Approval Date N/A Apr 28, 2017
Manufacturer N/A Takeda Pharmaceuticals America, Inc.
Route N/A ORAL
Marketing Status N/A Prescription